Lannett Voluntarily Pays Down $25 Million Of Term Loans

PHILADELPHIA, Feb. 7, 2018 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the company voluntarily made a $25 million payment against its Term Loans.

Lannett Logo (PRNewsFoto/Lannett Company, Inc.)

"Paying down our debt is a key priority," said Tim Crew, chief executive officer of Lannett.  "This $25 million payment will save us approximately $1.7 million in annualized cash interest expense, at current rates."

About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.  For more information, visit the company's website at www.lannett.com.

This news release contains certain statements of a forward-looking nature relating to future events or future business performance.  Any such statements, including, but not limited to, continuing to reduce outstanding debt, whether expressed or implied, are subject to risks and uncertainties which can cause actual results to differ materially from those currently anticipated due to a number of factors which include, but are not limited to, the difficulty in predicting the timing or outcome of FDA or other regulatory approvals or actions, the ability to successfully commercialize products upon approval, including acquired products, and Lannett's estimated or anticipated future financial results, future inventory levels, future competition or pricing, future levels of operating expenses, product development efforts or performance, and other risk factors discussed in the company's Form 10-K and other documents filed with the Securities and Exchange Commission from time to time.  These forward-looking statements represent the company's judgment as of the date of this news release.  The company disclaims any intent or obligation to update these forward-looking statements.

Contact: 

Robert Jaffe


Robert Jaffe Co., LLC


(424) 288-4098

 

SOURCE Lannett Company, Inc.


print email rss
Lannett Investor Relations
Lannett Company Products